Full Show: Using the Newly Approved Isatuximab in the Myeloma Clinic with Tom Martin, MD, USCS
MC RADIO - July 01, 2020
Thomas Martin, MD University of California at San Francisco Interview Date: June 5, 2020 Thanks to our episode sponsor Summary New treatment opti... Read More
Another Bi-Specific Antibody for Multiple Myeloma Treatment
Another Bi-Specific Antibody for Multiple Myeloma Treatment
MYELOMA NEWS - July 01, 2020
It seems that hardly a week goes by without news of progress in the fight against multiple myeloma. This time it comes (again) from Johnson & Johnson, the m... Read More
HealthTree University: Multiple Myeloma Basics Part 2 (1 of 2)
HealthTree University: Multiple Myeloma Basics Part 2 (1 of 2)
HEALTHTREE - July 01, 2020
As in most things, the most important information can be simple, like knowing what tests you should be getting. Not all cancer doctors get this right, and it&rs... Read More
The Power of Our Cancer Stories
LIFE WITH MYELOMA - June 30, 2020
When a cancer diagnosis hits, it's natural to want to share your experience with others. Sharing your story is emotionally healing and it can have a powerfu... Read More
July 11 Interactive Webcast: Using Three New Myeloma Therapies (Selinexor, Isatuximab, Darzalex FasPro) with Three Myeloma Experts
UPCOMING MC ROUND TABLES - June 29, 2020
Learn about three new therapies being incorporated in myeloma treatment Register Now Isatuximab (Sarclisa™), selinexor (XPOVIO&t... Read More
Good News: Long Term Follow Up of Revlimid/Velcade/Dex Use
MYELOMA NEWS - June 28, 2020
We are inundated with snippets of news from a host of clinical studies reporting interesting (and even exciting) results for us, myeloma patients. The caveat wi... Read More
COVID-19 Food Funds for Myeloma Patients Provided by Team Rubicon and Bristol Myers Squibb
LIFE WITH MYELOMA - June 25, 2020
Although we are all tired of COVID-19, it continues to affect the United States and myeloma patients need to continue to take precautions to protect themselves.... Read More
Which Myeloma Drug will You Respond To? Mayo Clinic Scottsdale Researchers Develop New Test
MYELOMA NEWS - June 25, 2020
Myeloma specialists and myeloma patients alike want to know which treatment will work best before they are taken. The Mayo Clinic Scottsdale has developed a new... Read More
Meet Myeloma Coach Heidi Thomas: Knowledge is Power
MYELOMA COACH - June 25, 2020
When I was diagnosed with Multiple Myeloma in 2014, I had never heard of the disease and I had no idea where to turn. I was young with three kids aged 13,... Read More
HealthTree University: Multiple Myeloma Basics Part 1 (3 of 3)
HEALTHTREE - June 25, 2020
Myeloma can be complicated! It’s not staged like other cancers. How do you know if your myeloma is even considered active cancer? It can be inside or outs... Read More
Progress on Another CAR -T for Multiple Myeloma!
MYELOMA NEWS - June 22, 2020
It was only a few years ago that the Myeloma Crowd started to post the first articles about CAR-T and the potential promise this medical breakthrough could be f... Read More
EHA 2020: Ixazomib is Effective as Maintenance for Transplant Ineligible Myeloma Patients
MYELOMA NEWS - June 18, 2020
Much of the maintenance therapy used in myeloma care includes immunomodulators like Revlimid or Pomalyst, but a presentation from the European Hematology Associ... Read More
How to Choose a Health Insurance Plan When Considering Early Retirement
MYELOMA COACH - June 18, 2020
We are in a unique environment with the impact of COVID-19, The economic impact has left countless people without jobs and in financially tenuous circumstances.... Read More
